Clinical Trial Update: A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers [NA]

View source ↗

Summary

An update on a completed study evaluating the immunogenicity of intradermal Bacille Calmette-Guérin (BCG) vaccine in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: University of Oxford | Conditions: TB | NA | Status: COMPLETED